Updated On: 18 May, 2021 12:00 AM IST | New Delhi | PTI
An Indian Council of Medical Research (ICMR) official said the task force "revised" the Clinical Guidance for Management of Adult Covid-19 Patients and "dropped convalescent plasma (off label)".

Photo used for representational purpose. Pic/AFP
The government on Monday revised the clinical guidance for Covid-19 treatment, dropping the off-label use of convalescent plasma as it was found not beneficial in reducing the progression to severe disease or death.
The development came following a meeting of the ICMR-National Task Force for Covid-19 last week wherein all members were in favour of removing the use of convalescent plasma from the guidelines citing its ineffectiveness and inappropriate use in several cases.